Quarterly Result6 Aug 2026, 10:41 pm
Sai Life Sciences Declares Unaudited Q1 FY27 Results
AI Summary
Sai Life Sciences Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated financial results, along with the limited review report from statutory auditors Deloitte Haskins & Sells LLP. The company also noted the allotment of 506,782 equity shares due to employee stock option exercises during the quarter. The results were prepared in accordance with Indian Accounting Standards (Ind AS) and SEBI regulations.
Key Highlights
- Board approved unaudited standalone and consolidated financial results for Q1 FY27.
- Limited review report from statutory auditors Deloitte Haskins & Sells LLP noted.
- 506,782 equity shares allotted upon exercise of employee stock options.
- Results prepared as per Ind AS and SEBI (LODR) Regulations, 2015.
- Board meeting held on August 06, 2026, from 8:10 PM to 9:00 PM IST.
Price Impact
More from SAILIFE
More in Quarterly Result